Investing

Goldman Sachs says buy this biotech stock with more than 60% upside

The investment bank initiated coverage of the pharmaceuticals stock with a buy rating.

adminadmin
Jun 6, 2024 - 03:00
 0  35
Goldman Sachs says buy this biotech stock with more than 60% upside
The investment bank initiated coverage of the pharmaceuticals stock with a buy rating.
Read More

Tags:

Previous Article

Bitcoin is on the verge of a bullish breakout again. What to watch on the charts

Next Article

Here are Wednesday's biggest analyst calls: Apple, Nvidia, Amazon, Meta, Uber, D...

admin
admin

Related Posts

Here's how an 86-year-old grandmother got her nearly $32,000 private student loan debt forgiven

Here's how an 86-year-old grandmother got her nearly $3...

admin Nov 2, 2024  0  8

55-year-old Americans are 'critically underprepared' for retirement, survey finds

55-year-old Americans are 'critically underprepared' fo...

admin Jun 27, 2024  0  7

These stocks reporting this week are cheap and well liked by analysts

These stocks reporting this week are cheap and well lik...

admin Oct 29, 2024  0  6